MEDICAL LETTER ON DRUGS AND THERAPEUTICS

打开微信扫一扫

期刊ISSN

0025-732X

E-ISSN

1523-2859

影响因子

登录后查看数据

自引率

35.7%

SCI期刊JCR分区

SCI期刊JCR分区等级：4区

按学科分区
PHARMACOLOGY & PHARMACY Q4
PHARMACOLOGY & PHARMACY Q4

《新锐期刊分区表》

（2026年3月发布）

大类学科	小类学科	Top期刊	综述期刊
医学 4区	药学 4区	否	否

最新中科院SCI期刊分区

（2025年3月升级版）

大类学科	小类学科	Top期刊	综述期刊
医学 4区	药学 4区	否	否

期刊简介

The Medical Letter, Inc. is committed to providing objective, practical, and timely information on drugs and treatments of common diseases to help our readers make the best decisions for their patients—without the influence of the pharmaceutical industry. The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides: Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings Consensus recommendations for the preferred and alternative treatments for common disorders Comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost.

出版信息
出版商	Medical Letter Inc.
期刊官网	http://www.nih.gov/
涉及的研究方向	医学-药学
刊期	Biweekly
年文章数	9
出版国家或地区	UNITED STATES
是否OA	否
SCI期刊收录coverage	Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore)